CAR T-cell Therapy Market to Reach US$ 21.8 Bn by 2031, Industry Players Aim at Better Therapies for Patients with Hematological Malignancy and Solid Tumors: TMR Study
/PRNewswire/ -- The growing clinical effectiveness of the treatment of chimeric antigen receptors (CAR) T-cell therapies in various hematological malignancies,...